355,691 UnitedHealth Group Incorporated $UNH Shares Sold by International Assets Investment Management LLC

International Assets Investment Management LLC decreased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 83.6% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 70,000 shares of the healthcare conglomerate’s stock after selling 355,691 shares during the quarter. International Assets Investment Management LLC’s holdings in UnitedHealth Group were worth $25,696,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in UNH. City State Bank increased its holdings in shares of UnitedHealth Group by 5.6% in the third quarter. City State Bank now owns 471 shares of the healthcare conglomerate’s stock valued at $173,000 after purchasing an additional 25 shares during the period. Murphy Pohlad Asset Management LLC lifted its holdings in shares of UnitedHealth Group by 0.5% during the third quarter. Murphy Pohlad Asset Management LLC now owns 5,305 shares of the healthcare conglomerate’s stock worth $1,947,000 after purchasing an additional 25 shares during the period. LFG Wealth Partners LLC boosted its position in UnitedHealth Group by 3.3% in the second quarter. LFG Wealth Partners LLC now owns 853 shares of the healthcare conglomerate’s stock valued at $355,000 after buying an additional 27 shares during the last quarter. Synergy Financial Group LTD increased its holdings in UnitedHealth Group by 3.1% in the 2nd quarter. Synergy Financial Group LTD now owns 887 shares of the healthcare conglomerate’s stock worth $369,000 after buying an additional 27 shares during the period. Finally, Ares Financial Consulting LLC increased its holdings in UnitedHealth Group by 7.2% in the 2nd quarter. Ares Financial Consulting LLC now owns 419 shares of the healthcare conglomerate’s stock worth $174,000 after buying an additional 28 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

UNH has been the topic of a number of research reports. Wells Fargo & Company cut their price objective on shares of UnitedHealth Group from $526.00 to $487.00 and set an “overweight” rating on the stock in a research note on Tuesday. Barclays lowered their price target on shares of UnitedHealth Group from $441.00 to $440.00 and set an “overweight” rating on the stock in a report on Wednesday, October 14th. Mizuho increased their price target on UnitedHealth Group from $493.00 to $500.00 and gave the stock an “outperform” rating in a research report on Thursday, October 22nd. HC Wainwright set a $500.00 price objective on UnitedHealth Group in a research note on Friday, October 16th. Finally, Robert W. Baird lowered their target price on UnitedHealth Group from $453.00 to $427.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 14th. Twenty research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus target price of $463.93.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Improving margins and higher price target: Morgan Stanley said UnitedHealth’s margins are recovering, with Medicare operations returning to a more normal range, and raised its price target. However, commercial insurance, Medicaid and increased AI-related spending remain important execution tests. UnitedHealth is bouncing back, but a major risk remains
• Positive Sentiment: Recent earnings beat and raised guidance: UnitedHealth’s latest quarterly results exceeded expectations for both earnings and revenue, and the company raised its outlook. The earnings recovery supports the case that operating performance is stabilizing after earlier pressure. Why Did UnitedHealth Raise Guidance After Its Quarterly Beat?
• Positive Sentiment: Dividend appeal: UnitedHealth is highlighted as a major healthcare dividend payer, potentially supporting demand from income-focused investors. The article also cautions that dividend safety should be assessed alongside payout sustainability and business risks. $250,000 in Merck, Pfizer, UnitedHealth and AbbVie Could Pay $8,000 a Year in Dividends
• Neutral Sentiment: Analyst estimates are mixed: Zacks Research maintained a “Hold” rating and projects roughly $20.54 in FY2026 EPS, close to the broader consensus near $20.62. It raised several longer-term quarterly estimates but lowered others, including Q1 2027, Q1 2028 and Q2 2028.
• Negative Sentiment: Near-term earnings pressure: Zacks Research issued a negative estimate for fourth-quarter earnings, adding to concerns that high medical utilization and costs could limit profitability despite the Medicare recovery. Zacks Research Has Negative Estimate for UNH Q4 Earnings

UnitedHealth Group Stock Down 1.0%

UNH opened at $406.67 on Friday. The company has a fifty day moving average of $390.20 and a two-hundred day moving average of $362.40. The stock has a market capitalization of $365.02 billion, a price-to-earnings ratio of 23.23, a PEG ratio of 1.49 and a beta of 0.60. UnitedHealth Group Incorporated has a fifty-two week low of $255.96 and a fifty-two week high of $461.62. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The business had revenue of $112.70 billion for the quarter, compared to analyst estimates of $111.31 billion. During the same period in the prior year, the company posted $2.59 EPS. The company’s revenue for the quarter was down .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, research analysts expect that UnitedHealth Group Incorporated will post 20.61 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th were issued a $2.32 dividend. This represents a $9.28 annualized dividend and a yield of 2.3%. The ex-dividend date of this dividend was Monday, September 14th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 53.00%.

Insider Buying and Selling

In other news, CEO Patrick Conway sold 1,169 shares of the business’s stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the sale, the chief executive officer directly owned 15,328 shares in the company, valued at $5,977,920. The trade was a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 0.19% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.